Maternal B vitamin status in pregnancy week 18 according to reported use of folic acid supplements

Molecular Nutrition and Food Research

Volumn 57, Issue 4, 2013, Pages 645-652

  Bjørke Monsen, Anne Lise ^a   Roth, Christine ^b   Magnus, Per ^b,c   Midttun, Øivind ^d   Nilsen, Roy M ^a,b   Reichborn Kjennerud, Ted ^b,c   Stoltenberg, Camilla ^b   Susser, Ezra ^e   Vollset, Stein Emil ^b,f   Ueland, Per Magne ^a,d,f  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d BEVITAL AS   (Norway)

^e Department of Medicine   (United States)

^f UNIVERSITY OF BERGEN   (Norway)

Author keywords

B vitamin status; Folic acid; Micronutrients; Periconceptional; Pregnancy

Indexed keywords

BIOLOGICAL MARKER; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHYLMALONIC ACID; OMEGA 3 FATTY ACID; PYRIDOXINE; RIBOFLAVIN; TRACE ELEMENT; VITAMIN B COMPLEX;

ADULT; ARTICLE; BLOOD; DIET SUPPLEMENTATION; FEMALE; HUMAN; MATERNAL NUTRITION; NORWAY; PREGNANCY; PROSPECTIVE STUDY; QUESTIONNAIRE; SOCIOECONOMICS;

ADULT; BIOLOGICAL MARKERS; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; METHYLMALONIC ACID; MICRONUTRIENTS; NORWAY; PREGNANCY; PROSPECTIVE STUDIES; QUESTIONNAIRES; RIBOFLAVIN; SOCIOECONOMIC FACTORS; VITAMIN B 12; VITAMIN B 6; VITAMIN B COMPLEX;

EID: 84875868685     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200114     Document Type: Article

References (41)

1. Czeizel, A. E., Dudas, I., Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 1992, 327, 1832-1835.
2. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 1991, 338, 131-137.
3. Berry, R. J., Li, Z., Erickson, J. D., Li, S. et al., Prevention of neural-tube defects with folic acid in China. China-U.S. collaborative project for neural tube defect prevention. N. Engl. J. Med. 1999, 341, 1485-1490.
4. Shaw, G. M., Schaffer, D., Velie, E. M., Morland, K. et al., Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 1995, 6, 219-226.
5. Werler, M. M., Shapiro, S., Mitchell, A. A., Periconceptional folic acid exposure and risk of occurrent neural tube defects. Jama 1993, 269, 1257-1261.
6. U.S. Preventive Services Task Force. Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 2009, 150, 626-631.
7. Botto, L. D., Lisi, A., Robert-Gnansia, E., Erickson, J. D. et al., International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ 2005, 330, 571.
8. Dhaulakhandi, D. B., Rohilla, S., Rattan, K. N., Neural tube defects: review of experimental evidence on stem cell therapy and newer treatment options. Fetal. Diagn. Ther. 2010, 28, 72-78.
9. Daltveit, A. K., Vollset, S. E., Lande, B., Oien, H., Changes in knowledge and attitudes of folate, and use of dietary supplements among women of reproductive age in Norway 1998-2000. Scand. J. Public Health 2004, 32, 264-271.
10. Centers for Disease Control and Prevention (CDC). Trends in folic acid supplement intake among women of reproductive age - California, 2002-2006. MMWR Morb. Mortal Wkly. Rep. 2007, 56, 1106-1109.
11. Nilsen, R. M., Vollset, S. E., Gjessing, H. K., Magnus, P. et al., Patterns and predictors of folic acid supplement use among pregnant women: the Norwegian Mother and Child Cohort Study. Am. J. Clin. Nutr. 2006, 84, 1134-1141.
12. Savage, D. G., Lindenbaum, J., Stabler, S. P., Allen, R. H., Serum methylmalonic acid and total homocysteine in the diagnosis of deficiencies of cobalamin and folate. Am. J. Med. 1994, 96, 239-246.
13. Midttun, O., Ulvik, A., Ringdal Pedersen, E., Ebbing, M. et al., Low plasma vitamin B-6 status affects metabolism through the kynurenine pathway in cardiovascular patients with systemic inflammation. J. Nutr. 2010, 141, 611-617.
14. Magnus, P., Irgens, L. M., Haug, K., Nystad, W. et al., Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa). Int. J. Epidemiol. 2006, 35, 1146-1150.
15. Ronningen, K. S., Paltiel, L., Meltzer, H. M., Nordhagen, R. et al., The biobank of the Norwegian Mother and Child Cohort Study: a resource for the next 100 years. Eur. J. Epidemiol. 2006, 21, 619-625.
16. Nilsen, R. M., Vollset, S. E., Monsen, A. L., Ulvik, A. et al., Infant birth size is not associated with maternal intake and status of folate during the second trimester in Norwegian pregnant women. J. Nutr. 2010, 140, 572-579.
17. O'Broin, S., Kelleher, B., Microbiological assay on microtitre plates of folate in serum and red cells. J. Clin. Pathol. 1992, 45, 344-347.
18. Kelleher, B. P., Broin, S. D., Microbiological assay for vitamin B12 performed in 96-well microtitre plates. J. Clin. Pathol. 1991, 44, 592-595.
19. Baril, L., Carmel, R., Comparison of radioassay and microbiological assay for serum folate, with clinical assessment of discrepant results. Clin. Chem. 1978, 24, 2192-2196.
20. Windelberg, A., Arseth, O., Kvalheim, G., Ueland, P. M., Automated assay for the determination of methylmalonic acid, total homocysteine, and related amino acids in human serum or plasma by means of methylchloroformate derivatization and gas chromatography-mass spectrometry. Clin. Chem. 2005, 51, 2103-2109.
21. Midttun, O., Hustad, S., Ueland, P. M., Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2009, 23, 1371-1379.
22. R Development Core Team, R A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna 2008.
23. Nilsen, R. M., Vollset, S. E., Gjessing, H. K., Skjaerven, R. et al., Self-selection and bias in a large prospective pregnancy cohort in Norway. Paediatr. Perinat. Epidemiol. 2009, 23, 597-608.
24. O'Broin, J. D., Temperley, I. J., Scott, J. M., Erythrocyte, plasma, and serum folate: specimen stability before microbiological assay. Clin. Chem. 1980, 26, 522-524.
25. Hannisdal, R., Ueland, P. M., Eussen, S. J., Svardal, A. et al., Analytical recovery of folate degradation products formed in human serum and plasma at room temperature. J. Nutr. 2009, 139, 1415-1418.
26. McDonnell, R., Johnson, Z., Doyle, A., Sayers, G., Determinants of folic acid knowledge and use among antenatal women. J. Public Health Med. 1999, 21, 145-149.
27. Carmichael, S. L., Shaw, G. M., Yang, W., Laurent, C. et al., Correlates of intake of folic acid-containing supplements among pregnant women. Am. J. Obstet. Gynecol. 2006, 194, 203-210.
28. de Jong-Van den Berg, L. T., Hernandez-Diaz, S., Werler, M. M., Louik, C. et al., Trends and predictors of folic acid awareness and periconceptional use in pregnant women. Am. J. Obstet. Gynecol. 2005, 192, 121-128.
29. James, W. P., Nelson, M., Ralph, A., Leather, S., Socioeconomic determinants of health. The contribution of nutrition to inequalities in health. BMJ 1997, 314, 1545-1549.
30. Blumenshine, P., Egerter, S., Barclay, C. J., Cubbin, C. et al., Socioeconomic disparities in adverse birth outcomes: a systematic review. Am. J. Prev. Med. 2010, 39, 263-272.
31. Mortensen, L. H., Helweg-Larsen, K., Andersen, A. M., Socioeconomic differences in perinatal health and disease. Scand. J. Public Health 2011, 39, 110-114.
32. Daly, L. E., Kirke, P. N., Molloy, A., Weir, D. G. et al., Folate levels and neural tube defects. Implications for prevention. JAMA 1995, 274, 1698-1702.
33. Cuskelly, G. J., McNulty, H., Scott, J. M., Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet 1996, 347, 657-659.
34. McNulty, B., Pentieva, K., Marshall, B., Ward, M. et al., Women's compliance with current folic acid recommendations and achievement of optimal vitamin status for preventing neural tube defects. Hum. Reprod. 2011, 26, 1530-1536.
35. van Guldener, C., Stehouwer, C. D., Homocysteine-lowering treatment: an overview. Expert Opin. Pharmacother. 2001, 2, 1449-1460.
36. Ulvik, A., Ebbing, M., Hustad, S., Midttun, O. et al., Long- and short-term effects of tobacco smoking on circulating concentrations of B vitamins. Clin. Chem. 2010, 56, 755-763.
37. Goedhart, G., van der Wal, M. F., van Eijsden, M., Bonsel, G. J., Maternal vitamin B-12 and folate status during pregnancy and excessive infant crying. Early Hum. Dev. 2010, 87, 309-314.
38. Metz, J., McGrath, K., Bennett, M., Hyland, K. et al., Biochemical indices of vitamin B12 nutrition in pregnant patients with subnormal serum vitamin B12 levels. Am. J. Hematol. 1995, 48, 251-255.
39. Bruinse, H. W., van den Berg, H., Changes of some vitamin levels during and after normal pregnancy. Eur. J. Obstet Gynecol. Reprod. Biol. 1995, 61, 31-37.
40. Murphy, M. M., Molloy, A. M., Ueland, P. M., Fernandez-Ballart, J. D. et al., Longitudinal study of the effect of pregnancy on maternal and fetal cobalamin status in healthy women and their offspring. J. Nutr. 2007, 137, 1863-1867.
41. Midttun, O., Ulvik, A., Ringdal Pedersen, E., Ebbing, M. et al., Low plasma vitamin B-6 status affects metabolism through the kynurenine pathway in cardiovascular patients with systemic inflammation. J. Nutr. 2011, 141, 611-617.